Published by Misasa Medical Center, Okayama University Medical School
Published by Misasa Medical Center, Okayama University Medical School

<Formerly known as>
岡大三朝分院研究報告 (63号-72号) 環境病態研報告 (57号-62号)
岡山大学温泉研究所報告 (5号-56号) 放射能泉研究所報告 (1号-4号)

<Availability>
Some items are not available because of decision by its author or publisher.

Candida-specif ic IgG(4) ant ibodies and bronchial asthma

Tanizaki, Yoshiro
Kitani, Hikaru
Okazaki, Morihiro
Mifune, Takashi
Mitsunobu, Fumihiro Kaken ID publons researchmap
Takatori, Akimasa
Okuda, Hiroyuki
Harada, Hideo
Abstract
Serum levels of Candida-specific IgG(4) antibodies were examined in 66 patients with bronchial asthma, relating to patient age and asthma severity. 1. The levels of Candida-specific IgG(4) antibodies were the highest in patients with 60+years of age, compared to the levels in cases with 0-39 and 40-59 years of age. 2. In cases with 40-59 years of age, the levels of Candida-specific IgG(4) were significantly higher in cases with long-term steroid therapy (severe intractable asthma) than in cases without steroid regimen. The results suggest that increased levels of Candida-specific IgG(4) were observed in relation to patient age and asthma severity.
Keywords
Candida (カンジダ)
Sepcific IgG(4) (特異的IgG(4))
Bronchial asthma (気管支喘息)
Aging (加齢)
Asthma severity (喘息重症度)
ISSN
0913-3771
NCID
AN10084718
NAID